Moving around before your vitamin drip appointment helps ensure a successful IV treatment
Foundayo (orforglipron) is Eli Lilly's oral GLP-1 medication for chronic weight management, FDA-approved on April 1, 2026
Although we are consuming fewer calories, we are not necessarily depriving ourselves of essential nutrients
Understanding the Limitations of Obesity: Obesity has many challenges
Nat Rev Nephrol (2018) 15:2744
Seek urgent same-day assessment or call 999 for emergency care if experiencing: Severe chest pain Severe shortness of breath Fainting or collapse Acute or rapidly worsening neurological deficits (such as new limb weakness, sudden gait disturbance, or bladder/bowel dysfunction) Persistent or worsening anaemia symptoms despite treatmentincluding breathlessness, chest discomfort, palpitations, or extreme fatigueshould trigger medical review